JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Environment/Superfund ENV
- S.1009, "Chemical Safety Improvement Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREL C JODREY | — |
Financial Institutions/Investments/Securities FIN
- HR 1135, "Burdensome Data Collection Relief Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
Taxation/Internal Revenue Code TAX
- Issues regarding tax reform. - HR 1248, "Family Health Care Flexibility Act", regarding all provisions. - Issues related to tax legislation. - Issues related to Ways and Means and Senate Finance tax reform discussion drafts.- HR 1129, "Mobile Workforce State Income Tax Simplification Act of 2013", regarding all provisions. - HR 2992, "Business Activity Tax Simplification Act", regarding all provisions. - HR 2835, "Restoring Access to Medication Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| GREGORY ARONIN | — |
| DON BOHN | — |
| BRIAN BURNS | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
Copyright/Patent/Trademark CPT
- Issues related to patent reform. - Issues related to legislative proposals on patent "trolls".
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES NAU | — |
Health Issues HCR
- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - HR 2375, "Competitive Bidding for DME Delay", regarding all provisions. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - HR 2085, "Diagnostic Payment Reform", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - S. 1871, "SGR Repeal and Medicare Beneficiary Access Act of 2013", regarding all provisions. - Issues related to health care associated infections. - S. 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| GREGORY ARONIN | — |
| DON BOHN | — |
| BRIAN BURNS | — |
| JULIE D COHEN | — |
| KIMBERLY DAVIS | — |
| LAURYL DODSON JACKSON | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
| CHARLES NAU | — |
| MARK REESE | — |
Budget/Appropriations BUD
- Issues related to ADAP funding. - Issues related to FDA funding. - Issues related to Alzheimer's funding. - Issues related to appropriations/debt ceiling.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BURNS | — |
| JULIE D COHEN | — |
| DARREL C JODREY | — |
| CHARLES NAU | — |
| MARK REESE | — |
Consumer Issues/Safety/Products CSP
- Issues related to dextromethorphan. - Issues related to pseudoephedrine. - Issues related to the regulation of cosmetic products. - HR 1385, "Safe Cosmetics and Personal Care Products Act of 2013", regarding all provisions.- S 644, "Preventing Abuse of Cough Treatments Act of 2013", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DON BOHN | — |
| DARREL C JODREY | — |
Trade (domestic/foreign) TRD
- Issues related to current and future trade negotiations. - Issues related to TransPacific Partnership trade negotiations. - Issues related to TransAtlantic Trade and Investment Partnership negotiations. - Issues related to Trade Promotion Authority.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
Medicare/Medicaid MMM
- Issues related to Medicare reimbursement for Clinical Laboratory Services. - HR 8, "American Taxpayer Relief Act of 2012", regarding all provisions in Section 636. - HR 800, "To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare", regarding all provisions.- Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues related to implantable medical devices. - Issues related to diabetes care products. - Issues related to competitive bidding of diabetes care products. - Issues related to health care pricing transparency. - Issues related to Medicare reimbursement for joint replacement procedures. - Issues related to OIG study regarding competitive bidding draft legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
| JULIE D COHEN | — |
| LAURYL DODSON JACKSON | — |
| MARK REESE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.